(Q36616439)

15 August 2017

Patient motivations surrounding participation in phase I and phase II clinical trials of cancer chemotherapy (English)

1 reference

15 August 2017

phase I clinical trial

0 references

phase II clinical trial

0 references

1 reference

1 reference

Z A Nurgat

1 reference

15 August 2017

W Craig

1 reference

15 August 2017

N C Campbell

1 reference

15 August 2017

J D Bissett

1 reference

15 August 2017

J Cassidy

1 reference

15 August 2017

M C Nicolson

1 reference

15 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

British Journal of Cancer

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

1 reference

15 August 2017

1001-1005

1 reference

Phase I trial design for solid tumor studies of targeted, non-cytotoxic agents: theory and practice

15 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Striking the right balance in colorectal cancer care--a qualitative study of rural and urban patients

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Cancer patients' information needs and information seeking behaviour: in depth interview study.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Patients in phase I trials of anti-cancer agents in Japan: motivation, comprehension and expectations

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Volunteers or victims: patients' views of randomised cancer clinical trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

False hopes and best data: consent to research and the therapeutic misconception

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Responses and toxic deaths in phase I clinical trials

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Ethical issues in phase I oncology research: a comparison of investigators and institutional review board chairpersons

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Impact of quality of life on patient expectations regarding phase I clinical trials.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Expectations and experiences of patients with cancer participating in phase I clinical trials

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

The recruitment of patients into clinical trials

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Patient motivation and informed consent in a phase I study of an anticancer agent

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Trends in the risks and benefits to patients with cancer participating in phase 1 clinical trials

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Patients' understanding of risk

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Perceptions of cancer patients and their physicians involved in phase I trials

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Informed consent for investigational chemotherapy: patients' and physicians' perceptions

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2361930

Strategic physician communication and oncology clinical trials

21 October 2018

1 reference

12 December 2020

Informed consent and decision-making: patients' experiences of the process of recruitment to phases I and II anti-cancer drug trials

1 reference

12 December 2020

Assessing the quality of life of patients in phase I and II anti-cancer drug trials: interviews versus questionnaires

1 reference

12 December 2020

Therapeutic misconception and the appreciation of risks in clinical trials

1 reference

12 December 2020

Response rates, duration of response, and dose response effects in phase I studies of antineoplastics

1 reference

12 December 2020

The Belmont Report. Ethical principles and guidelines for the protection of human subjects of research

1 reference

12 December 2020

Therapeutic response in phase I trials of antineoplastic agents

1 reference

12 December 2020

Design and results of phase I cancer clinical trials: three-year experience at M.D. Anderson Cancer Center

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.BJC.6602423

1 reference

15 August 2017

1 reference

15 August 2017

PubMed publication ID

15770219

1 reference